Skip to main content
Signal8

GREAT POINT PARTNERS LLC

GREAT POINT PARTNERS LLC is an Investment Adviser institutional filer with the SEC under CIK 1281446, reporting 37 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in GREAT POINT PARTNERS LLC's most recent 13F filing, ranked by reported market value.

  1. VOR BIOPHARMA INC (VOR)
  2. ABIVAX SA (ABVX)
  3. VERA THERAPEUTICS INC (VERA)
  4. ZURA BIO LTD (ZURA)
  5. ALUMIS INC (ALMS)
  6. SOL-GEL TECHNOLOGIES LTD (SLGL)
  7. DEFINIUM THERAPEUTICS INC (DFTX)
  8. ANNEXON INC (ANNX)
  9. ORUKA THERAPEUTICS INC (ORKA)
  10. MOONLAKE IMMUNOTHERAPEUTICS (MLTX)
/